IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q2 2015 Holdings

Filed 2015-08-14 | 18 holdings | $34.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$33.4M3,608,17198.1%
Esperion Therapeutics Inc.(ESPR)COM29664W105$133.9K1,637,1250.4%
Zeltiq Aesthetics IncCOM98933Q108$76.7K2,602,7380.2%
Cempra IncCOM15130J109$75.4K2,193,0600.2%
Loxo Oncology IncCOM548862101$62.2K3,452,4930.2%
Chimerix Inc.(CMRXEUR)COM16934W106$47.3K1,022,9430.1%
T2 Biosystems IncCOM89853L104$41.0K2,523,3000.1%
Versartis IncCOM92529L102$34.7K2,279,5680.1%
Sorrento Therapeutics Inc(SRNE)COM NEW83587F202$30.0K1,703,8550.1%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$25.6K2,983,7970.1%
Transenterix Inc.COM NEW89366M201$25.0K8,335,8190.1%
Catalent Inc(CTLTEUR)COM148806102$21.0K715,6730.1%
Dermira Inc(DERMEUR)COM24983L104$19.3K1,102,0460.1%
Paratek Pharmaceuticals IncCOM699374302$17.6K682,6800.1%
Pernix Therapeutics Hldgs inCOM71426V108$11.9K2,010,0000.0%
Intersect ENT IncCOM46071F103$10.0K350,0000.0%
Lombard MED IncCOMG55598109$3.9K886,3630.0%
Roka Bioscience IncCOM775431109$2.7K1,029,6930.0%